No profile data available.
Cresco Labs Inc. (CRLBF) is an essential consumer products company in the marijuana product manufacturing industry, based in Chicago, United States, with about 2,900 full-time employees.
It reported revenue of $655.85 million for fiscal year 2025, down 9.5% from fiscal year 2024, and net income of -$135.41 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $173.34 million, up 5.9% from a year before. Its largest business segment, Dispensary, brought in 66% of segment revenue in fiscal year 2025. Its market capitalization was $240.62 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
Cresco Labs reported $655.85 million in revenue for fiscal year 2025, down 9.5% from $724.34 million in fiscal year 2024. In Q2 2026 revenue was $173.34 million.
Dispensary, with $433.08 million or 66% of segment revenue in fiscal year 2025. Next: Wholesale (34%).
$240.62 million as of October 9, 2026.
Listed companies of a similar size in the same industry (marijuana product manufacturing) include Vireo Growth Inc. (VREOF), Canopy Growth Corporation (CGC), Aurora Cannabis Inc. (ACB), Organigram Global Inc. (OGI).